HMGB1 mediates synaptic loss and cognitive impairment in an animal model of sepsis-associated encephalopathy

HMGB1 induces microglial activation, aberrant synaptic pruning, and neuron dysfunction in an animal model of SAE, leading to cognitive impairment. These results suggest that HMGB1 might be a target for SAE treatment.